Computerized oral prescription administration for securely dispensing a medication and associated systems and methods

Abstract

In one embodiment, a member for securely dispensing a substance to an intended user includes a first member configured to threadedly engage with a housing containing the substance; a second member coupled to the first member, the second member configured to fixedly secure the first member to the housing; a third member including a cavity sized and shaped to selectively receive the second member; and a valve coupled to the first member such that: when the second member is received within the cavity, the valve is in an open state that allows the substance to be dispensed from the housing to the intended user in response to a processor determining that a unique biometric attribute of the intended user is detected, and when the second member is not received within the cavity, the valve is in a closed state that prevents the substance from being dispensed from the housing.

Description

[0001] Cross References to Related Applications [0002] This application claims priority to and benefit of U.S. Patent Application Serial No. 16 / 420,002, filed May 22, 2019, which is hereby incorporated by reference in its entirety. technical field [0003] The present disclosure generally relates to pharmaceutical oral dosing devices and computerized oral prescription administration (COPA) devices. For example, locking caps can be implemented on medicine bottles to prevent unauthorized access to the medicine and help to safely dispense the medicine only to the intended user. Background technique [0004] The history of pharmacology is the history of the continuous development of routes of administration, drug formulations, dosage forms, and dosing devices in the continual search to maximize the effective benefits and reduce the relative costs of prescribed drugs. Administration of a prescription substance may take place in a controlled healthcare setting, eg, in a health...

AI Technical Summary

Problems solved by technology

However, to avoid extra steps and potential audit scrutiny, some physicians may refuse to prescribe pain management or short-term pain and may refer all cases to a pain clinic

[0011] Attempts to improve patient education, stronger labeling, and restrictive prescribing result in increased costs for providers, patients, pharmacies, and insurers, while reducing overall effectiveness for patients

Finally, opioids are poorly accessible to people with true pain disorders, and opioid abusers continue to manipulate available access regardless of apparent negligence

Policies and programs at all levels are not successful and do not do enough to control or reduce prescription drug abuse

Images